The current biomarkers pepsinogen, carcinoembryonic antigen (CEA), and carbohydrate antigen 19–9 (CA19–9), are not sufficient for accurately predicting gastric cancer at an early stage [8], [9], [10]. Here, CEACAM5 is linked to gastric cancer.